RNAZ
TRANSCODE THERAPEUTICS, INC.Marquee-fund ownership over time
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Citadel Advisors | Q3 2024 | Q4 2024 | — | +0% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at Transcode Therapeutics, Inc.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from Jun 18, 2024 — the most recent Form 4 on file — not from today.
- Form 40001104659-24-072826Jun 18, 2024
- Form 40001104659-24-072825Jun 18, 2024
- Form 40001104659-24-072820Jun 18, 2024
- Form 40001104659-24-072817Jun 18, 2024
- Form 40001104659-23-105925Oct 2, 2023
- Form 40001104659-23-105924Oct 2, 2023
- Form 40001104659-23-073872Jun 22, 2023
- Form 4/Aamend0001104659-23-071204Jun 14, 2023
- Form 40001104659-23-070804Jun 13, 2023
- Form 40001104659-23-062816May 19, 2023
- Form 40001104659-23-062815May 19, 2023
- Form 40001104659-23-062814May 19, 2023
- Form 40001104659-23-062813May 19, 2023
- Form 40001104659-23-062812May 19, 2023
- Form 40001104659-23-058582May 10, 2023
Fundamentals
XBRL · TRANSCODE THERAPEUTICS, INC.Annual figures sourced directly from TRANSCODE THERAPEUTICS, INC.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for Transcode Therapeutics, Inc. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 8-KFORM 8-KJun 3, 2026
- DEF 14AProxy statementJun 2, 2026
- 8-KFORM 8-KJun 1, 2026
- 8-K/AFORM 8-K/AMay 26, 2026
- 8-KFORM 8-KMay 22, 2026
- 10-QQuarterly reportMay 15, 2026
- S-1Registration (IPO)May 1, 2026
- S-3FORM S-3Apr 30, 2026
- 10-K/AAnnual report (amended)Apr 30, 2026
- 10-KAnnual reportApr 15, 2026
- 8-KFORM 8-KApr 7, 2026
- 8-KFORM 8-KMar 3, 2026
- 8-KFORM 8-KFeb 23, 2026
- 8-KFORM 8-KFeb 5, 2026
- 8-KFORM 8-KJan 6, 2026
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Citadel Advisors | Q3 2024 | Q4 2024 | $0.00 | — | +0% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.